These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8899004)

  • 21. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.
    Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG
    Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective evaluation of prostate cancer detection by prostate specific antigen related parameters: comparison in serum and plasma samples.
    Egawa S; Suyama K; Matsumoto K; Kuwao S; Baba S
    J Urol; 2002 Jan; 167(1):97-102. PubMed ID: 11743284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
    Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
    Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
    Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
    Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostate-specific antigen (PSA) in women].
    Kamenov Z; Todorova M; Khristov V
    Vutr Boles; 2001; 33(1):40-7. PubMed ID: 11785088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer.
    Heyl W; Wolff JM; Biesterfeld S; Schröder W; Zitzelsberger D; Jakse G; Rath W
    Anticancer Res; 1999; 19(4A):2563-5. PubMed ID: 10470195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer.
    Sauter ER; Klein G; Wagner-Mann C; Diamandis EP
    Cancer Detect Prev; 2004; 28(1):27-31. PubMed ID: 15041074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
    Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
    Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparability of serum prostate-specific antigen measurement between the Roche Diagnostics Elecsys 2010 and the Abbott Architect i2000.
    Gray MA; Cooke RR; Weinstein P; Nacey JN
    Ann Clin Biochem; 2004 May; 41(Pt 3):207-12. PubMed ID: 15117434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?
    Etzioni R; Falcon S; Gann PH; Kooperberg CL; Penson DF; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1640-5. PubMed ID: 15466981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inadequacy of prostate-specific antigen doubling time estimates calculated using an ultrasensitive assay of prostate-specific antigen for biochemical failure after radical prostatectomy.
    Shimizu F; Matsuyama Y; Tominaga T; Ohashi Y; Fujime M
    Urol Int; 2007; 79(4):356-60. PubMed ID: 18025856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum.
    Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V
    J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination of breast cancer by measuring prostate-specific antigen levels in women's serum.
    Chang YF; Hung SH; Lee YJ; Chen RC; Su LC; Lai CS; Chou C
    Anal Chem; 2011 Jul; 83(13):5324-8. PubMed ID: 21591802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H; Koide T; Kuriyama M; Ban Y; Deguchi T; Kawada Y
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values.
    Semjonow A; Brandt B; Oberpenning F; Roth S; Hertle L
    Prostate Suppl; 1996; 7():3-16. PubMed ID: 8950358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.